UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer

ONCOLOGY

Volumn 14, Issue 10 SUPPL. 9, 2000, Pages 47-49

  Gregory, R K ^a   Johnston, S R D ^a   Smith, I E ^a   Miles, D ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FOLINIC ACID; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPIRUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MIDDLE AGED; NEUTROPENIA; TEGAFUR; URACIL;

EID: 0034305703     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Jones AL, Smith IE, O'Brien ME, et al: Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer. An active new regimen. J Clin Oncol 12:1259-1265, 1994.
2. Eisen T, Smith IE, Johnston S, et al: A randomized phase II trial of infusional 5-fluorouracil, epirubicin and cyclophosphamide versus infusional 5-fluorouracil, epirubicin and cisplatin in patients with advanced breast cancer. J Clin Oncol 16:1350-1357, 1998.
3. Puig-la Calle J, Lopez Sanchez S, Piedrafita Serra E, et al: Totally implanted device for long-term intravenous chemotherapy: Experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273-278, 1996.